GB0420970D0 - Novel triazoloquinoline compounds - Google Patents

Novel triazoloquinoline compounds

Info

Publication number: GB0420970D0
Authority: GB; United Kingdom
Prior art keywords: triazoloquinoline; novel; compounds; triazoloquinoline compounds; novel triazoloquinoline
Prior art date: 2004-09-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GB0420970A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Corp

Original Assignee

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-21

Filing date

2004-09-21

Publication date

2004-10-20

2004-09-21 Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp

2004-09-21 Priority to GB0420970A priority Critical patent/GB0420970D0/en

2004-10-20 Publication of GB0420970D0 publication Critical patent/GB0420970D0/en

2005-09-19 Priority to TW094132221A priority patent/TW200621772A/en

2005-09-19 Priority to PCT/EP2005/010177 priority patent/WO2006032470A1/en

2005-09-19 Priority to PE2005001075A priority patent/PE20060818A1/en

2005-09-20 Priority to ARP050103899A priority patent/AR051089A1/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Psychology (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

GB0420970A 2004-09-21 2004-09-21 Novel triazoloquinoline compounds Ceased GB0420970D0 (en)

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
GB0420970A GB0420970D0 (en)	2004-09-21	2004-09-21	Novel triazoloquinoline compounds
TW094132221A TW200621772A (en)	2004-09-21	2005-09-19	Compounds which increase apolipoprotein a-1 production and uses thereof in medicine
PCT/EP2005/010177 WO2006032470A1 (en)	2004-09-21	2005-09-19	Compounds which increase apolipoprotein a-1 production and uses thereof in medicine
PE2005001075A PE20060818A1 (en)	2004-09-21	2005-09-19	TRIAZOLOQUINOLEIN COMPOUNDS THAT INCREASE APOLIPOPROTEIN A-1 PRODUCTION
ARP050103899A AR051089A1 (en)	2004-09-21	2005-09-20	TRIAZOLOQUINOLEINE AND TRIAZOLONAFTIRIDINE SUBSTITUTED COMPOUNDS

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB0420970A GB0420970D0 (en)	2004-09-21	2004-09-21	Novel triazoloquinoline compounds

Publications (1)

Publication Number	Publication Date
GB0420970D0 true GB0420970D0 (en)	2004-10-20

Family

ID=33306953

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB0420970A Ceased GB0420970D0 (en)	2004-09-21	2004-09-21	Novel triazoloquinoline compounds

Country Status (5)

Country	Link
AR (1)	AR051089A1 (en)
GB (1)	GB0420970D0 (en)
PE (1)	PE20060818A1 (en)
TW (1)	TW200621772A (en)
WO (1)	WO2006032470A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7572771B1 (en)	2004-10-15	2009-08-11	The United States Of America As Represented By The Departments Of Health And Human Services	Multi-domain amphipathic helical peptides and methods of their use
JP2010510317A (en) *	2006-11-20	2010-04-02	ブリストル−マイヤーズスクイブカンパニー	7,8-Dihydro-1,6-naphthyridin-5 (6H) -one and related bicyclic compounds as inhibitors of dipeptidyl peptidase IV, and methods
WO2010049103A1 (en) *	2008-10-31	2010-05-06	Eth Zurich	Soluble truncated apom proteins and medical uses thereof
US8680116B2 (en)	2009-07-22	2014-03-25	Merck Sharp & Dohme Corp.	Quinolinone PDE2 inhibitors
JP5524343B2 (en)	2009-11-05	2014-06-18	グラクソスミスクラインエルエルシー	Benzodiazepine bromodomain inhibitor
SI2496582T1 (en)	2009-11-05	2016-04-29	Glaxosmithkline Llc Corporation Service Company	Benzodiazepine bromodomain inhibitor
GB0919432D0 (en)	2009-11-05	2009-12-23	Glaxosmithkline Llc	Use
RU2438672C1 (en) *	2010-04-30	2012-01-10	Общество с ограниченной ответственностью "Клевер Фарм"	Agent showing properties of cognitive function activator (versions)
US9085582B2 (en)	2010-06-22	2015-07-21	Glaxosmithkline Llc	Benzotriazolodiazepine compounds inhibitors of bromodomains
WO2013097052A1 (en)	2011-12-30	2013-07-04	Abbott Laboratories	Bromodomain inhibitors
CN104334526A (en)	2012-04-20	2015-02-04	艾伯维公司	Isoindolone derivatives
BR112014031068A2 (en)	2012-06-12	2017-06-27	Abbvie Inc	pyridinone and pyridazinone derivatives
EP2989096B1 (en)	2013-04-26	2019-04-10	BeiGene, Ltd.	Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones
ES2793239T3 (en)	2016-04-15	2020-11-13	Abbvie Inc	Bromodomain inhibitors
WO2021048852A1 (en)	2019-09-11	2021-03-18	Yeda Research And Development Co. Ltd.	Methods of treating breast cancer
WO2021257863A1 (en)	2020-06-19	2021-12-23	Incyte Corporation	Pyrrolotriazine compounds as jak2 v617f inhibitors
US11691971B2 (en)	2020-06-19	2023-07-04	Incyte Corporation	Naphthyridinone compounds as JAK2 V617F inhibitors
US11767323B2 (en)	2020-07-02	2023-09-26	Incyte Corporation	Tricyclic pyridone compounds as JAK2 V617F inhibitors
TW202216713A (en)	2020-07-02	2022-05-01	美商英塞特公司	Tricyclic urea compounds as jak2 v617f inhibitors
WO2022046989A1 (en)	2020-08-27	2022-03-03	Incyte Corporation	Tricyclic urea compounds as jak2 v617f inhibitors
US11919908B2 (en)	2020-12-21	2024-03-05	Incyte Corporation	Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
EP4298099A1 (en)	2021-02-25	2024-01-03	Incyte Corporation	Spirocyclic lactams as jak2 v617f inhibitors
WO2023165528A1 (en) *	2022-03-01	2023-09-07	Insilico Medicine Ip Limited	Diacylglycerol kinase (dgk) alpha inhibitors and uses thereof
CN118871438A (en)	2022-03-01	2024-10-29	英矽智能科技知识产权有限公司	Diacylglycerol kinase (DGK) alpha inhibitors and uses thereof
WO2023178285A1 (en)	2022-03-17	2023-09-21	Incyte Corporation	Tricyclic urea compounds as jak2 v617f inhibitors
WO2024181437A1 (en) *	2023-02-28	2024-09-06	中外製薬株式会社	Nitrogen-containing heterocyclic compound having myt1 inhibitory activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS50116498A (en) *	1974-02-27	1975-09-11
BR0114253A (en) *	2000-10-02	2003-07-01	Janssen Pharmaceutica Nv	Metabotropic Glutamate Receptor Antagonists
GB0108475D0 (en) *	2001-04-04	2001-05-23	Merck Sharp & Dohme	New compounds

2004
- 2004-09-21 GB GB0420970A patent/GB0420970D0/en not_active Ceased
2005
- 2005-09-19 PE PE2005001075A patent/PE20060818A1/en not_active Application Discontinuation
- 2005-09-19 WO PCT/EP2005/010177 patent/WO2006032470A1/en active Application Filing
- 2005-09-19 TW TW094132221A patent/TW200621772A/en unknown
- 2005-09-20 AR ARP050103899A patent/AR051089A1/en unknown

Also Published As

Publication number	Publication date
AR051089A1 (en)	2006-12-20
PE20060818A1 (en)	2006-08-16
WO2006032470A1 (en)	2006-03-30
TW200621772A (en)	2006-07-01

Publication	Publication Date	Title
GB0400812D0 (en)	2004-02-18	Novel compounds
EP1718638A4 (en)	2009-04-22	Novel compounds
GB0409744D0 (en)	2004-06-09	Novel compounds
GB0420970D0 (en)	2004-10-20	Novel triazoloquinoline compounds
GB0405628D0 (en)	2004-04-21	Novel compounds
GB0402140D0 (en)	2004-03-03	Novel compounds
GB0402496D0 (en)	2004-03-10	Novel compounds
GB0402357D0 (en)	2004-03-10	Novel compounds
EP1805132A4 (en)	2010-01-20	Novel compounds
EP1796793A4 (en)	2009-08-05	Novel compounds
GB0408083D0 (en)	2004-05-12	Novel compounds
GB0402355D0 (en)	2004-03-10	Novel compounds
GB0402812D0 (en)	2004-03-10	Novel compounds
GB0402356D0 (en)	2004-03-10	Novel compounds
GB0402380D0 (en)	2004-03-10	Novel compounds
GB0404105D0 (en)	2004-03-31	Novel compounds
GB0408445D0 (en)	2004-05-19	Novel compounds
GB0408447D0 (en)	2004-05-19	Novel compounds
GB0406032D0 (en)	2004-04-21	Novel compounds
GB0406031D0 (en)	2004-04-21	Novel compounds
GB0406030D0 (en)	2004-04-21	Novel compounds
GB0406029D0 (en)	2004-04-21	Novel compounds
GB0406027D0 (en)	2004-04-21	Novel compounds
GB0407391D0 (en)	2004-05-05	Novel compounds
GB0404579D0 (en)	2004-04-07	Novel compounds

Legal Events

Date	Code	Title	Description
2006-01-11	AT	Applications terminated before publication under section 16(1)